We do need a wider selection of treatments for all points along the #bladdercancer pathway. Clinical effectiveness plus QoL info so patients have real choices. #EAU18 https://t.co/hOvKjslU01
We do need a wider selection of treatments for all points along the #bladdercancer pathway. Clinical effectiveness plus QoL info so patients have real choices. #EAU18 https://t.co/hOvKjslU01